Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beta Carotene Linked With Decreased Adenoma Recurrence In Nonsmokers

This article was originally published in The Tan Sheet

Executive Summary

Beta carotene supplementation helps prevent colorectal adenoma recurrence in patients that do not smoke or consume high levels of alcohol, according to a study in the May 21 Journal of the National Cancer Institute

You may also be interested in...



FDA Keeps Door Open To Help Observational Studies Work For Health Claims

FDA says in a final guidance that observational studies alone are insufficient support for health claims, but the agency also says it is interested in making it easier for those studies to support claims

FDA Keeps Door Open To Help Observational Studies Work For Health Claims

FDA says in a final guidance that observational studies alone are insufficient support for health claims, but the agency also says it is interested in making it easier for those studies to support claims

FDA Keeps Door Open To Help Observational Studies Work For Health Claims

FDA says in a final guidance that observational studies alone are insufficient support for health claims, but the agency also says it is interested in making it easier for those studies to support claims

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095517

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel